PRECHECK HEALTH SERVICES INC
NPI 1760076061
Clinical Medical Laboratory in Miami, FL
NPI Status: Active since February 26, 2021
Contact Information
100 BISCAYNE BLVD STE 1212
MIAMI, FL
ZIP 33132
Phone: (305) 203-4711
- Organization
- Clinical Medical Laboratory
- CLIA Number: 10D2210020
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 05-10-2028
About PRECHECK HEALTH SERVICES INC
This page provides the complete NPI Profile along with additional information for Precheck Health Services Inc, a provider established in Miami, Florida operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1760076061 assigned on February 2021. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 5 years ago. The authorized official of this NPI record is Frank Gillen (Authorized Official)
- NPI
- 1760076061
- Provider Name
- PRECHECK HEALTH SERVICES INC
- Entity Type
- Organization
- Location Address
- 100 BISCAYNE BLVD STE 1212 MIAMI, FL 33132
- Location Phone
- (305) 203-4711
- Mailing Address
- 100 BISCAYNE BLVD STE 1212 MIAMI, FL 33132
- Mailing Phone
- (305) 203-4711
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 02-26-2021
- Last Update Date
- 05-18-2021
- Code Navigator
Establishments like Precheck Health Services Inc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Secondary Taxonomies
The provider has reported to the NPI enumerator additional taxonomy codes. Multiple taxonomy codes may represent subspecialties or other areas of specialization the provider maybe licensed to practice.
| No. | Taxonomy Code | Type | Classification / Specialization |
License No. (State) |
|---|---|---|---|---|
| 1 | 293D00000X | Laboratories | Physiological Laboratory |
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants
Gene analysis (adenomatous polyposis coli), full gene sequence
Gene analysis (ataxin 2) for abnormal alleles
Gene analysis (bloom syndrome, recq helicase-like)
Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants
Gene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence
Gene analysis (coagulation factor ix) full sequence analysis
Gene analysis (coagulation factor v) leiden variant
Gene analysis (cystic fibrosis transmembrane conductance regular) duplication or deletion variants
Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence
Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants
Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants
Gene analysis (fanconi anemia, complementation group c) common variant
Gene analysis (frataxin) of full sequence
Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis
Gene analysis (hemochromatosis) common variants
Gene analysis (janus kinase 2) targeted sequence analysis
Gene analysis (methyl cpg binding protein 2) duplication or deletion variants
Gene analysis (methyl cpg binding protein 2) full sequence analysis
Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis
Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis
Gene analysis (muts homolog 6 [e coli]) full sequence analysis
Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis
Gene analysis (partner and localizer of brca2) full sequence analysis
Gene analysis (phosphatase and tensin homolog), full sequence analysis
Gene analysis (phospholipase c gamma 2) for common variants
Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis
Gene analysis (prothrombin, coagulation factor ii) a variant
Gene analysis (runt related transcription factor 1) targeted sequence analysis
Gene analysis (tata box binding protein) for abnormal alleles
Gene analysis (tumor protein 53) full sequence analysis
Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence
Gene analysis panel for hereditary disorders of the peripheral nervous system
Genomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Molecular pathology procedure level 1
Molecular pathology procedure level 2
Molecular pathology procedure level 7
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Test for detecting genes
Test for detecting genes associated with disease, genomic sequence, must include sequence analysis of entire mitochondrial genome
Test for detecting genes associated with disease, whole mitochondrial genome
Test for detecting genes associated with intellectual disability, duplication/deletion gene analysis, at least 60 genes
Test for detecting genes associated with rheumatoid arthritis using immunoassay technique
Gene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.
This service was performed 40 times for 40 patientsGene analysis of the adenomatous polyposis coli (APC) involves studying the entire sequence of the APC gene. This test helps identify mutations that could lead to conditions like familial adenomatous polyposis. The procedure is non-invasive and uses a blood sample.
This service was performed 98 times for 98 patientsGene analysis for ataxin 2 checks for alterations in the ATXN2 gene. This gene is responsible for producing a protein essential for normal cell functions. If abnormal, it may lead to certain neurological disorders. The test involves analyzing your DNA, typically obtained via a blood sample.
This service was performed 38 times for 38 patientsGene analysis for Bloom Syndrome involves studying the RECQ helicase-like gene. This gene is responsible for DNA repair. When it's not working properly, it can lead to Bloom Syndrome, a condition that increases the risk of developing various types of cancer.
This service was performed 94 times for 94 patientsGene analysis for breast cancer 1 and 2 involves studying your DNA to detect alterations that may increase your risk of developing certain health issues. This test analyzes the full sequence and checks for duplication or deletion variants.
This service was performed 52 times for 52 patientsGene analysis of the CCAAT/Enhancer Binding Protein (C/EBP), Alpha, involves studying the entire sequence of this particular gene. This can help identify variations or changes in the gene that might affect your health. This process is done in a lab using a sample of your cells.
This service was performed 120 times for 120 patientsGene analysis for coagulation factor IX is a process that examines your genes, specifically the one responsible for factor IX - a protein that helps blood clot. It can detect any changes or mutations in this gene, which could affect your body's ability to control bleeding.
This service was performed 96 times for 96 patientsGene analysis for the coagulation factor V Leiden variant is a test to identify a specific genetic mutation. This mutation can increase the risk of developing abnormal blood clots in veins. The test involves analyzing a sample of your DNA, usually taken from a blood sample.
This service was performed 50 times for 50 patientsGene analysis for cystic fibrosis checks for duplication or deletion variants in the CFTR gene. These changes can affect the body's salt balance, leading to thick, sticky mucus in the lungs and other organs. This test helps in early detection and management of the disease.
This service was performed 31 times for 31 patientsGene analysis for cystic fibrosis involves examining the entire CFTR gene to identify any changes or mutations that could cause the disease. This can help in diagnosing and managing the condition effectively.
This service was performed 140 times for 138 patientsGene analysis of cytochrome P450 2C19 common variants is a test that helps understand how your body processes certain medications. This can help your doctor tailor treatments specifically for you, improving their effectiveness and safety.
This service was performed 26 times for 26 patientsGene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.
This service was performed 49 times for 49 patientsGene analysis for Fanconi Anemia, Complementation Group C, is a test that looks at your DNA to see if you have changes in a specific gene linked to this type of anemia. This can help determine if you have the condition or if you might pass it on to your children.
This service was performed 66 times for 66 patientsGene analysis of frataxin involves studying the entire sequence of the frataxin gene. This test helps identify any changes or mutations in the gene that may cause health issues, such as Friedreich's ataxia. It's a non-invasive procedure using a blood sample.
This service was performed 37 times for 37 patientsGene analysis for glucose-6-phosphate dehydrogenase (G6PD) involves studying your DNA to check for changes in the G6PD gene. This gene controls an enzyme that helps red blood cells function properly. Anomalies can cause health issues like anemia.
This service was performed 123 times for 123 patientsGene analysis for hemochromatosis common variants is a test that checks for specific changes in your DNA. These changes could indicate a higher risk of developing hemochromatosis, a condition that causes your body to absorb too much iron from your diet.
This service was performed 44 times for 44 patientsGene analysis, specifically Janus Kinase 2 (JAK2) targeted sequence analysis, is a lab test that studies a specific gene in your body. It helps identify changes or mutations in the JAK2 gene, which can be linked to certain health conditions. This analysis is performed on a blood or bone marrow sample.
This service was performed 120 times for 120 patientsGene analysis for Methyl CpG Binding Protein 2 (MECP2) duplication or deletion variants is a test that investigates changes in the MECP2 gene. This gene is crucial for brain development. Variations can lead to various health conditions. The test involves analyzing a sample of your DNA to identify these changes.
This service was performed 33 times for 33 patientsGene analysis, specifically Methyl CpG Binding Protein 2 (MECP2) full sequence analysis, is a detailed examination of your DNA. This test focuses on the MECP2 gene, which plays a crucial role in nerve cell function and development. The results can help identify alterations or mutations that may cause certain health conditions.
This service was performed 71 times for 71 patientsGene analysis, specifically for MUTL Homolog 1, linked to colon cancer, involves studying your DNA sequence. This helps identify any changes or mutations that might increase your risk of developing colon cancer. It's a preventive measure to manage potential health risks.
This service was performed 31 times for 31 patientsGene analysis (MUTYH) full sequence analysis is a test that examines your DNA to identify any changes linked to nonpolyposis colon cancer type 1. This can help determine your risk of developing this type of cancer.
This service was performed 30 times for 30 patientsGene analysis, specifically MUTS Homolog 6 (E. coli) full sequence analysis, is a test that examines your DNA to identify changes in the MUTS Homolog 6 gene. This information helps doctors understand and manage potential health concerns.
This service was performed 22 times for 22 patientsGene analysis, specifically neurotrophic receptor tyrosine kinase 2 (NTRK2) translocation analysis, is a test that studies alterations in your genes. This analysis helps identify changes in the NTRK2 gene, which can sometimes be linked to certain health conditions. It's a vital part of personalized medicine.
This service was performed 33 times for 33 patientsGene analysis, specifically for the partner and localizer of BRCA2, involves examining your genetic code to identify any changes in this particular gene. This gene is significant in maintaining the health of your cells. The full sequence analysis means we look at every part of this gene to ensure it's working properly.
This service was performed 150 times for 150 patientsGene analysis, specifically phosphatase and tensin homolog (PTEN) full sequence analysis, is a test that looks at your DNA to identify any changes in the PTEN gene. This gene helps control cell growth and division. Changes may lead to certain health conditions.
This service was performed 179 times for 179 patientsGene analysis for phospholipase C gamma 2 common variants is a test that checks for changes in the PLCG2 gene. These changes can sometimes lead to certain health conditions. The test uses a sample of your body's cells to analyze your DNA.
This service was performed 158 times for 158 patientsGene analysis, specifically postmeiotic segregation increased 2 (s cerevisiae) full sequence analysis, is a scientific procedure. It involves studying your entire genetic code to identify any changes or differences that could be related to certain health conditions. This is done in a lab, using a sample provided by you.
This service was performed 23 times for 23 patientsGene analysis for prothrombin (also known as coagulation factor II) is a test that examines your DNA to identify any variations in the prothrombin gene. These variations could potentially affect blood clotting, leading to an increased risk of certain health conditions.
This service was performed 55 times for 55 patientsGene analysis for RUNX1 involves studying a specific part of your DNA. This test helps identify changes or mutations in the RUNX1 gene, which can provide insights into certain health conditions. It's like reading a book to find any spelling mistakes that could change the story.
This service was performed 111 times for 110 patientsGene analysis for the TATA box binding protein checks for abnormal alleles or variations in your DNA. This analysis helps identify potential genetic conditions. It's done by examining a sample of your cells, typically obtained through a blood draw or a cheek swab.
This service was performed 38 times for 38 patientsGene analysis, specifically tumor protein 53 (TP53) full sequence analysis, is a test that examines the entire TP53 gene. This gene plays a key role in preventing cancer. If there are changes or mutations in this gene, it could lead to an increased risk of developing various types of cancer.
This service was performed 229 times for 228 patientsGene analysis of v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog (KIT) is a test that studies a specific gene associated with cell growth and development. It helps in identifying any alterations in this gene that may lead to health issues.
This service was performed 104 times for 104 patientsA gene analysis panel for hereditary disorders of the peripheral nervous system is a test that checks for genetic mutations linked to certain nerve disorders. It helps identify if you have a higher risk of developing these conditions.
This service was performed 39 times for 39 patientsThis procedure involves analyzing your genetic material to identify specific mutations that could cause severe inherited conditions. It examines 15 or more genes. The information can help in diagnosis, treatment planning, and understanding your risk for certain diseases.
This service was performed 39 times for 39 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 1,008 times for 751 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 1,012 times for 752 patientsA Molecular Pathology Procedure Level 1 is a lab test that studies the genes in your cells. It helps identify alterations in your DNA that may cause or contribute to certain diseases. The procedure is non-invasive and helps in early disease detection.
This service was performed 87 times for 46 patientsA Molecular Pathology Procedure Level 2 is a laboratory test used to study genes at a molecular level. This helps identify genetic variations or mutations that may be associated with certain diseases or conditions. This information assists in diagnosing and managing your healthcare.
This service was performed 11 times for 11 patientsA Molecular Pathology Procedure Level 7 is a high-complexity lab test that examines genes or proteins at a molecular level. It aids in diagnosing diseases, understanding genetic conditions, or guiding treatment plans. This test is performed in a specialized lab.
This service was performed 58 times for 58 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 972 times for 722 patientsA gene detection test is a medical procedure that identifies specific genes in your DNA. It helps to understand your genetic makeup and potential health risks. The process involves taking a small sample of your body tissue, like blood or saliva, which is then analyzed in a lab.
This service was performed 39 times for 39 patientsThis test detects specific genes linked to diseases by analyzing the entire mitochondrial genome. It's like scanning a book for certain words. The procedure involves mapping the genomic sequence, which is the order of genes in your DNA, to identify potential health risks.
This service was performed 33 times for 33 patientsA test for the whole mitochondrial genome identifies changes in the mitochondrial DNA that may cause health issues. It involves taking a small sample of blood or tissue. The DNA is then examined for any changes linked to potential diseases.
This service was performed 71 times for 71 patientsThis test identifies changes in at least 60 genes linked to intellectual disability. It involves analyzing your DNA to find any duplications or deletions in these genes. This information can help in understanding and managing the condition.
This service was performed 118 times for 118 patientsThis procedure involves a blood test that uses an immunoassay technique to detect specific genes linked to rheumatoid arthritis. It helps identify your risk of developing the condition and can inform treatment strategies.
This service was performed 119 times for 119 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 10D2210020
- Facility Type
- Independent
- Certificate Effective Date
- May 11, 2026
- Certificate Expiration Date
- May 10, 2028
- Laboratory Director
- DR. LOURDES M. TRIGO
- Certificate Type
- Certificate of Accreditation
- Certificate Type Description
- This is a CLIA certificate is issued to Precheck Health Services Inc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.
Reviews for PRECHECK HEALTH SERVICES INC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1760076061, we treat the final digit (1) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 49. The final step is to find the difference between that total and the next multiple of ten (50 - 49 = 1).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 49 is 50. The difference is the calculated check digit.
Other Providers at the Same Location
The following 1 provider is registered at the same or a nearby location.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1760076061, enumerated as an "organization" on February 26, 2021.
The provider is located at 100 BISCAYNE BLVD STE 1212 MIAMI, FL 33132 and the phone number is (305) 203-4711.
Clinical Medical Laboratory with taxonomy code 291U00000X.